Dogwood Therapeutics, Inc. (DWTX)
1.11
+0.07
(+6.73%)
USD |
NASDAQ |
Nov 06, 10:26
Dogwood Therapeutics Net Income (Quarterly) : -11.53M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.53M |
| March 31, 2026 | -4.987M |
| December 31, 2025 | -3.780M |
| September 30, 2025 | -15.74M |
| June 30, 2025 | -3.807M |
| March 31, 2025 | -10.92M |
| December 31, 2024 | -7.728M |
| September 30, 2024 | -2.281M |
| June 30, 2024 | -1.050M |
| March 31, 2024 | -1.291M |
| December 31, 2023 | -1.103M |
| September 30, 2023 | -1.235M |
| June 30, 2023 | -1.441M |
| March 31, 2023 | -1.517M |
| Date | Value |
|---|---|
| December 31, 2022 | -2.045M |
| September 30, 2022 | -2.576M |
| June 30, 2022 | -3.667M |
| March 31, 2022 | -3.960M |
| December 31, 2021 | -4.511M |
| September 30, 2021 | -4.11M |
| June 30, 2021 | -4.283M |
| March 31, 2021 | -3.056M |
| December 31, 2020 | -6.501M |
| September 30, 2020 | -2.724M |
| June 30, 2020 | -0.6546M |
| September 30, 2019 | -0.8118M |
| June 30, 2019 | -0.5679M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 11.53M |
| EPS Diluted (Quarterly) | -0.3378 |
| Enterprise Value | 25.49M |
| Earnings Yield | -806.3% |
| Normalized Earnings Yield | -789.29 |